anonymous
Guest
anonymous
Guest
Lol! Can’t wait until they look at AuviQ.
I wonder how much those 2 sales reps were paid to go on and be interviewed? Your CEO was a deer in headlights. You guys are no different then Valeant. You will be gutted soon.
I wonder how much those 2 sales reps were paid to go on and be interviewed? Your CEO was a deer in headlights. You guys are no different then Valeant. You will be gutted soon.
Probably nothing. They were fishing for people to talk to them about 6months ago here on CP. Truth is, when someone leaves Kaleo, they are filled with so much hatred and disgust for this company that they’d do it for free. Terrible, toxic culture.
spencer did an awesome job explaining why it is PBM fault and Kaleo needed that price.
All good and doctors don't care cos our product rules compared to needle and nose spray
spencer did an awesome job explaining why it is PBM fault and Kaleo needed that price.
All good and doctors don't care cos our product rules compared to needle and nose spray
The fact is they soaked $142M from Medicare at $4k a pop is still hard to explain. If commercial insurance paid for it, that’s one thing, but the Senate report that comes out today, explains that the taxpayers paid full freight
‘The Senate committee found that Medicare was paying an average of $3,522 for each Evzio unit and Medicaid was paying an average of $2,412. Meanwhile, commercial health insurers were only paying an average of $367, which meant that government health care programs were subsidizing usage. It is worth noting that lawmakers have probed Kaleo over pricing tactics for its Auvi-Q allergic reaction device, an EpiPen rival’
Pricing tactics for AuviQ are just are shady. TriCare is the government payer probably getting milked the most. Who knows how ASPN is charging health plans? The reps sure don’t.
‘The Senate committee found that Medicare was paying an average of $3,522 for each Evzio unit and Medicaid was paying an average of $2,412. Meanwhile, commercial health insurers were only paying an average of $367, which meant that government health care programs were subsidizing usage. It is worth noting that lawmakers have probed Kaleo over pricing tactics for its Auvi-Q allergic reaction device, an EpiPen rival’
Pricing tactics for AuviQ are just are shady. TriCare is the government payer probably getting milked the most. Who knows how ASPN is charging health plans? The reps sure don’t.